Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 1c, Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Hims & Hers Health, Inc. Reports Record Fourth Quarter and Full Year 2022 Financial Results
February 27, 2023 4:15 PM ESTFull year 2022 revenue of $526.9 million, up 94% year-over-year
Q4 2022 record revenue of $167.2 million, up 97% year-over-year
Q4 2022 net loss of $10.9 million and achieves Adjusted EBITDA profitability of $3.9 million
Eclipses one million subscribers at year end, up 88% year-over-year
Provides Q1 and full year 2023 guidance, with full year 2023 revenue in the range of $735 million to $755 million and Adjusted EBITDA in the range of $20 million to $30 million
Introduces 2025 targets of at least $1.2 billion in revenue and $100 million in... More
